Targeting cellular gaps using Janus nanoparticles containing cationic polymers and surfactant lipids.

IF 1.9 Q3 PHARMACOLOGY & PHARMACY
Akihiro Matsumoto, Takeo Kitazawa, Yuta Hatori, Hiroshi Nakanishi, Chie Watanabe, Tomoya Takashima, Masahiro Murakami
{"title":"Targeting cellular gaps using Janus nanoparticles containing cationic polymers and surfactant lipids.","authors":"Akihiro Matsumoto,&nbsp;Takeo Kitazawa,&nbsp;Yuta Hatori,&nbsp;Hiroshi Nakanishi,&nbsp;Chie Watanabe,&nbsp;Tomoya Takashima,&nbsp;Masahiro Murakami","doi":"10.5582/ddt.2022.01118","DOIUrl":null,"url":null,"abstract":"<p><p>Since nanoparticles are taken up into cells by endocytosis, phagocytosis, or pinocytosis, they have been studied as intracellular drug carriers. Janus particles have an anisotropic structure composed of two or more distinct domains and have been proposed for use in various applications, including use as imaging agents or nanosensors. This study aimed to clarify the influence of the type of nanoparticles on their distribution in a human Caucasian colon adenocarcinoma (Caco-2) cell monolayer. We fabricated Janus and conventional spherical nanoparticles composed of pharmaceutically applicable ingredients. Janus and spherical nanoparticles composed of a cationic polymer and surfactant lipids were prepared by controlling the solvent removal pattern from the oil phase in the solvent removal process using the solvent evaporation and solvent diffusion methods. The distribution of nanoparticles in the Caco-2 cell monolayer was then evaluated using confocal laser microscopy. The mean hydrodynamic size of the fabricated Janus nanoparticles was 119.2 ± 4.6 nm. Distribution analysis using Caco-2 cells suggested that Janus nanoparticles were localized around the adherens junctions located just below the tight junction. Clear localization was not observed in non-Janus nanoparticles with the same composition. The clear localization of the Janus nanoparticles around the adherens junction may be due to their positive charge and asymmetric structure. Our results suggest the considerable potential for the development of nanoparticulate drug carriers to target cellular gaps.</p>","PeriodicalId":47494,"journal":{"name":"Drug Discoveries and Therapeutics","volume":"17 2","pages":"104-113"},"PeriodicalIF":1.9000,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discoveries and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5582/ddt.2022.01118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Since nanoparticles are taken up into cells by endocytosis, phagocytosis, or pinocytosis, they have been studied as intracellular drug carriers. Janus particles have an anisotropic structure composed of two or more distinct domains and have been proposed for use in various applications, including use as imaging agents or nanosensors. This study aimed to clarify the influence of the type of nanoparticles on their distribution in a human Caucasian colon adenocarcinoma (Caco-2) cell monolayer. We fabricated Janus and conventional spherical nanoparticles composed of pharmaceutically applicable ingredients. Janus and spherical nanoparticles composed of a cationic polymer and surfactant lipids were prepared by controlling the solvent removal pattern from the oil phase in the solvent removal process using the solvent evaporation and solvent diffusion methods. The distribution of nanoparticles in the Caco-2 cell monolayer was then evaluated using confocal laser microscopy. The mean hydrodynamic size of the fabricated Janus nanoparticles was 119.2 ± 4.6 nm. Distribution analysis using Caco-2 cells suggested that Janus nanoparticles were localized around the adherens junctions located just below the tight junction. Clear localization was not observed in non-Janus nanoparticles with the same composition. The clear localization of the Janus nanoparticles around the adherens junction may be due to their positive charge and asymmetric structure. Our results suggest the considerable potential for the development of nanoparticulate drug carriers to target cellular gaps.

使用含有阳离子聚合物和表面活性剂脂质的Janus纳米颗粒靶向细胞间隙。
由于纳米颗粒通过内吞作用、吞噬作用或胞饮作用进入细胞,因此它们被研究为细胞内药物载体。Janus粒子具有由两个或多个不同的结构域组成的各向异性结构,并被提议用于各种应用,包括用作显像剂或纳米传感器。本研究旨在阐明纳米颗粒类型对其在人高加索结肠腺癌(Caco-2)细胞单层中的分布的影响。我们制备了Janus和由药学上适用的成分组成的常规球形纳米颗粒。采用溶剂蒸发法和溶剂扩散法控制溶剂去除过程中油相的溶剂去除模式,制备了由阳离子聚合物和表面活性剂脂质组成的双面纳米颗粒和球形纳米颗粒。然后用激光共聚焦显微镜观察纳米颗粒在Caco-2细胞单层中的分布。制备的Janus纳米颗粒的平均水动力尺寸为119.2±4.6 nm。Caco-2细胞的分布分析表明,Janus纳米颗粒分布在粘附连接周围,位于紧密连接的正下方。在具有相同成分的非janus纳米颗粒中未观察到明确的定位。Janus纳米粒子在粘附结周围的清晰定位可能是由于它们的正电荷和不对称结构。我们的研究结果表明,开发靶向细胞间隙的纳米颗粒药物载体具有相当大的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Discoveries and Therapeutics
Drug Discoveries and Therapeutics PHARMACOLOGY & PHARMACY-
CiteScore
3.20
自引率
3.20%
发文量
51
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信